Recent Updates
Recently added Catalysts
ADMA Negative Sentiment Score: 25/100

ADMA Biologics Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

Key Takeaway: Rosen Law Firm has announced an investigation into ADMA Biologics, following claims that the company may have issued misleading business information to investors. This comes after a short seller report alleged that ADMA engaged in practices to inflate its revenue. As a result, the company's stock experienced a substantial decline of 16.6%. The law firm is preparing a class action lawsuit to seek recovery for investors who suffered losses due to these allegations.

Market Sentiment Analysis

CONCERNS & RISKS

  • ADMA Biologics is under investigation for possible misleading information to investors.
  • The company's stock fell 16.6% following allegations of revenue inflation practices.
  • Class action lawsuits are being prepared, indicating significant investor dissatisfaction.

Full Press Release Details

NEW YORK, April 18, 2026 (GLOBE NEWSWIRE) --
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of ADMA Biologics, Inc. (NASDAQ: ADMA) resulting from allegations that ADMA Biologics may have issued materially misleading business information to the investing public.
SO WHAT: If you purchased ADMA Biologics securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.
WHAT TO DO NEXT: To join the prospective class action, go to https://rosenlegal.com/submit-form/?case_id=57940 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email case@rosenlegal.com for information on the class action.
WHAT IS THIS ABOUT: On March 24, 2026, Investing.com published an article entitled “ADMA Biologics shares plunge on short seller allegations.” The article stated that ADMA Biologics shares fell “after short seller Culper Research released a report alleging the company engaged in channel stuffing to inflate revenue growth.”
On this news, ADMA Biologics stock fell 16.6% on March 24, 2026.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. At the time Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
Toll Free: (866) 767-3653

Tags

Frequently Asked Questions

What is the reason for the Rosen Law Firm's investigation?

The investigation concerns potential securities claims for ADMA Biologics shareholders over misleading business information.

How can I join the class action for ADMA Biologics?

To join, visit https://rosenlegal.com/submit-form/?case_id=57940 or call 866-767-3653.

What happened to ADMA Biologics' stock on March 24, 2026?

The stock fell 16.6% after allegations of channel stuffing by short seller Culper Research.

Why choose the Rosen Law Firm for securities claims?

The firm has a strong track record in securities class actions and significant recovery for investors.

What recognition has the Rosen Law Firm achieved?

The firm has been ranked highly for securities class action settlements and has recovered millions for investors.

Last updated: Apr 18, 2026